Nokia expects that the future development of the metaverse, Web3, and AI will lead to a surge in network demand
Nokia expects that the development of the metaverse, Web3, and artificial intelligence in the future will lead to a surge in network demand, and plans to bridge this gap by 2030.
Their "2030 Technology Strategy Report" focuses on building future network architecture to serve emerging innovative markets. Network demand is expected to grow by 22% to 25%. Nokia will focus its investments on network equipment and services.
Nokia also focuses on value internet ecosystems, including decentralization, blockchain, and smart contracts. They plan to focus on human augmentation, spatial computing, and distributed processing in the metaverse field.
In addition, Nokia is using metaverse technology in South Australia to assist aircraft technicians and has conducted digital twin experiments in Finland.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI crude oil futures prices fall by more than 1%
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Crypto prices
More
